SAN MATEO, Calif., Nov. 10 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York City on Tuesday, November 11, 2008. Mr. DiTonno and Stephen Ghiglieri, Chief Financial Officer, will also be available to respond to questions during the breakout session immediately following the presentation.
Event: Rodman & Renshaw 10th Annual Healthcare Conference
Date: Tuesday, November 11, 2008
Time: 2:25 p.m. ET
Place: New York Palace Hotel, Holmes II (4th Floor)
The presentation will be webcast live and can be accessed by visiting the investor relations section of NeurogesX' website at http://www.neurogesx.com. The webcast will be archived for 15 days.
About NeurogesX, Inc.
NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on
developing and commercializing novel pain management therapies. Its initial
focus is on chronic peripheral neuropathic pain, including postherpetic
neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and
painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio
is led by its product candidate NGX-4010, a dermal patch designed to manage
pain associated with peripheral neuropathic pain condi
|SOURCE NeurogesX, Inc.|
Copyright©2008 PR Newswire.
All rights reserved